读取中,请稍候

00-00 00:00:00
--.--
0.00 (0.000%)
昨收盘:0.000今开盘:0.000最高价:0.000最低价:0.000
成交额:0成交量:0买入价:0.000卖出价:0.000
市盈率:0.000收益率:0.00052周最高:0.00052周最低:0.000
丽珠医药集团股份有限公司2012年半年度报告(英文版) 下载公告
公告日期:2012-08-18
Livzon Pharmaceutical Group Inc.
   2012 Semi-Annual Report
           August 2012
                                                         2012 semi-annual report of Livzon Pharmaceutical Group Inc.
                                          Content
Section 1 Important Notice............................................................................. 2
Section 2 Brief Introduction of the Company.................................................. 3
Section 3 Financial Highlights.........................................................................4
Section 4 Change of Share Capitals and Particulars of Shareholders...........8
Section 5 Particulars of Directors, Supervisors and Senior Executives....... 14
Section 6 Report of Board of Directors.........................................................19
Section 7 Important Events...........................................................................35
Section 8 Financial Reports..........................................................................57
Section 9 Catalog of Files for Reference....................................................180
                                            2012 semi-annual report of Livzon Pharmaceutical Group Inc.
                       Section 1 Important Notice
The Board of Directors (BOD), Board of Supervisors (BOS), directors,
supervisors and senior executives hereby guarantee that the data in the
present report contain no false representation, misleading statements and
serious omissions, and shall be severally and jointly liable for the authenticity,
accuracy and completeness of the content.
All directors of the company have attended the meeting of Board of Directors
examining this semi-annual report.
The financial statements have not been audited by the certified public
accountants.
Mr. Zhu Baoguo, Chairman of the company, Mr. An Ning, the principal in
charge of accounting, and Ms. Si Yanxia, the principal of the Accounting
Department hereby declare: We guarantee the authenticity and completeness
of the financial statements in this semi-annual report.
                                                               2012 semi-annual report of Livzon Pharmaceutical Group Inc.
                  Section 2 Brief Introduction of the Company
(I) Information about the company
A-share code                 000513                              B-share code
A-share abbreviation         Livzon Group                        B-share abbreviation       Livzon B
Stock exchange for listing
                             Shenzhen Stock Exchange
of the Company
Chinese name                 丽珠医药集团股份有限公司
Chinese abbreviation         丽 珠 集 团
English name                 LIVZON PHARMACEUTICAL GROUP INC.
English abbreviation         LIVZON GROUP
Legal representative         Zhu Baoguo
Registered address           No. 132, Guihua North Road, Gongbei, Zhuhai, Guangdong Province
Post code of registered      519020
address
Office address               Livzon Building, No. 132, Guihua North Road, Gongbei, Zhuhai, Guangdong Province
Post code of office address 519020
Website                      http://www.livzon.com.cn
Email                        zhlivzon@pub.zhuhai.gd.cn
(II) Contact persons and contact details
                                                                                  Representative of stock
                                               Secretary of BOD
                                                                                         affairs
Name                                    Li Rucai                                Wang Shuguang
Contact address                         Livzon Building, No. 132, Guihua North Livzon Building, No. 132, Guihua North
                                        Road, Gongbei, Zhuhai, Guang

  附件:公告原文
返回页顶